StockData
Benitec Biopharma Inc. logo

Benitec Biopharma Inc. (BNTC) stock

BNTCNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 8/30
$8.15−0.39 (-4.57%)

Close on Nov 17, 2026Market cap $284.29MP/E –Yield –

Benitec Biopharma revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Benitec Biopharma's revenue for the twelve months ending Mar 31, 2025 was $0, down 100.0% year over year. For fiscal 2024 it was $0, down 100.0% from the year before. The highest annual figure on record is $12.20M in fiscal 2019.

Annual revenue

PeriodPeriod endValueChange
FY2024Jun 30, 2024$0-100.0%
FY2023Jun 30, 2023$75.00K+2.7%
FY2022Jun 30, 2022$73.00K+23.7%
FY2021Jun 30, 2021$59.00K-42.2%
FY2020Jun 30, 2020$102.00K-99.2%
FY2019Jun 30, 2019$12.20M–

Quarterly revenue

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q3 FY2026CQ1 2026Mar 31, 2026$0–
Q2 FY2026CQ4 2025Dec 31, 2025$0–
Q1 FY2026CQ3 2025Sep 30, 2025$0–
Q3 FY2025CQ1 2025Mar 31, 2025$0–
Q2 FY2025CQ4 2024Dec 31, 2024$0–
Q1 FY2025CQ3 2024Sep 30, 2024$0–
Q4 FY2024CQ2 2024Jun 30, 2024$0-100.0%
Q3 FY2024CQ1 2024Mar 31, 2024$0-100.0%
Q2 FY2024CQ4 2023Dec 31, 2023$0-100.0%
Q1 FY2024CQ3 2023Sep 30, 2023$0–
Q4 FY2023CQ2 2023Jun 30, 2023$7.00K–
Q3 FY2023CQ1 2023Mar 31, 2023$54.00K+12.5%
Q2 FY2023CQ4 2022Dec 31, 2022$14.00K-44.0%
Q1 FY2023CQ3 2022Sep 30, 2022$0–
Q4 FY2022CQ2 2022Jun 30, 2022$0-100.0%
Q3 FY2022CQ1 2022Mar 31, 2022$48.00K+4700.0%
Q2 FY2022CQ4 2021Dec 31, 2021$25.00K+2400.0%
Q1 FY2022CQ3 2021Sep 30, 2021$0-100.0%
Q4 FY2021CQ2 2021Jun 30, 2021$2.00K-92.9%
Q3 FY2021CQ1 2021Mar 31, 2021$1.00K-98.7%
Q2 FY2021CQ4 2020Dec 31, 2020$1.00K-97.0%
Q1 FY2021CQ3 2020Sep 30, 2020$55.00K–
Q3 FY2020CQ1 2020Mar 31, 2020$28.00K–
Q2 FY2020CQ4 2019Dec 31, 2019$77.00K–
Q1 FY2020CQ3 2019Sep 30, 2019$33.00K–

More Benitec Biopharma figures

See a number that looks wrong?